PainchekASX:PCK +4.17% EV-to-FCF is -2.28 as of Jun. 27, 2026. The stock has 3 warning signs investors should review. Among 410 Healthcare Providers & Services companies, Painchek ranks worse than 243902.2% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Painchek's Enterprise Value is A$16.12 Mil.
Painchek's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-7.08 Mil. Therefore, Painchek's EV-to-FCF for today is -2.28.
The historical rank and industry rank for Painchek's EV-to-FCF or its related term are showing as below:
ASX:PCK'
s EV-to-FCF Range Over the Past 10 Years
Min: -88.06 Med: -7.91 Max: -2.42
Current: -2.42
During the past 13 years, the highest EV-to-FCF of Painchek was -2.42. The lowest was -88.06. And the median was -7.91.
ASX:PCK's EV-to-FCF is ranked worse than 100% of 410
companies
in the Healthcare Providers & Services industry
Industry Median: 17.435
vs ASX:PCK: -2.42
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Painchek's share price for today is A$0.10.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Painchek's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was A$-0.047.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Painchek EV-to-FCF Related Terms
Painchek EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Painchek's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Painchek's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Painchek EV-to-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Painchek's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Painchek's EV-to-FCF falls into.
Painchek's current Enterprise Value is A$16.12 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Painchek's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was A$-7.08 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Painchek (ASX:PCK) has a EV-to-FCF of -2.28 as of Jun. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Painchek and its competitors. According to the industry distribution chart, Painchek ranks #999999 out of 410 companies in the Healthcare Providers & Services industry.
Is Painchek's EV-to-FCF too high?
Painchek's current EV-to-FCF is -2.28. Based on the distribution chart, Painchek ranks #999999 out of 410 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Painchek's EV-to-FCF compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Painchek ranks #999999 out of 410 companies for EV-to-FCF. This places Painchek in the lower half of its industry. The industry median EV-to-FCF is 17.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Healthcare Providers & Services company?
The median EV-to-FCF among Healthcare Providers & Services companies is 17.44, based on 410 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Painchek and its competitors. For the Healthcare Providers & Services industry, the median EV-to-FCF is 17.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Painchek's current EV-to-FCF is -2.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Painchek stock overvalued right now?
Based on GuruFocus' analysis, Painchek (ASX:PCK) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.40, compared to a current price of A$0.10 — trading 75% below its estimated fair value. The current EV-to-FCF is -2.28. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Painchek (ASX:PCK), the current EV-to-FCF is -2.28 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Painchek Ltd is engaged in the development and commercialization of mobile medical device applications that provide pain assessment for individuals who are unable to communicate pain with carers. It operates in one segment, namely the sale of its pain assessment solutions. Its geographic segments include Australia, the United Kingdom, and Other countries, of which it generates the majority of its revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:PCK has been successfully added to your 